VBI Vaccines Inc/BC Shareholders' Equity
VBI Vaccines Inc/BC had Shareholders' Equity of -$5.47 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-05-15
- 2024-03-31: Stockholders' Equity Attributable to Parent -$5.47M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $7.53M.
- 2023-09-30: Stockholders' Equity Attributable to Parent $19.89M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $8.74M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2024-03-31 | -$5.47M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $7.53M 10-Q · filed 2024-05-15 |
| 2023-09-30 | $19.89M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $8.74M 10-Q · filed 2023-11-14 |
| 2023-03-31 | $45.02M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $64.16M 10-Q · filed 2024-05-15 |
| 2022-09-30 | $83.82M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $105.56M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $129.56M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $143.88M 10-K · filed 2024-04-16 |
| 2021-09-30 | $160.14M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $168.08M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $180.01M 10-Q · filed 2022-11-10 |
| 2020-12-31 | $171.71M 10-K · filed 2023-03-13 |
| 2020-09-30 | $165.81M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $126.61M 10-Q · filed 2021-11-08 |
| 2020-03-31 | $74.43M 10-Q · filed 2021-11-08 |
| 2019-12-31 | $88.25M 10-K · filed 2022-03-07 |
| 2019-09-30 | $97.22M 10-Q · filed 2020-11-02 |
| 2019-06-30 | $76.25M 10-Q · filed 2020-11-02 |
| 2019-03-31 | $86.69M 10-Q · filed 2020-11-02 |
| 2018-12-31 | $98.13M 10-K · filed 2021-03-02 |
| 2018-09-30 | $77.13M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $89.80M 10-Q · filed 2019-11-06 |
| 2018-03-31 | $106.46M 10-Q · filed 2019-11-06 |
| 2017-12-31 | $119.79M 10-K · filed 2020-03-05 |
| 2017-09-30 | $62.97M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $69.36M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $75.86M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $83.73M 10-K · filed 2019-02-25 |
| 2015-12-31 | $12.19M 10-K · filed 2018-02-26 |
| 2014-12-31 | -$9.43M 10-K · filed 2018-02-26 |